STOCK TITAN

[Form 4] Accenture PLC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Arun Sarin, a director of Accenture plc (ticker ACN), reported an acquisition on 08/15/2025 of 8,473 Class A ordinary shares via grant (Transaction Code A) of restricted share units. The grant was made pursuant to anti-dilution provisions tied to previously awarded RSUs to reflect Accenture's payment of a cash dividend. The reported price per share is $247.57, and the amount beneficially owned following the transaction is listed as 8,473 shares. The Form 4 was signed on behalf of Mr. Sarin by an attorney-in-fact on 08/18/2025.

Arun Sarin, direttore di Accenture plc (ticker ACN), ha comunicato in data 08/15/2025 l'acquisizione di 8.473 azioni ordinarie di classe A tramite attribuzione (Codice transazione A) di unità azionarie soggette a restrizioni. L'attribuzione è stata effettuata in applicazione di clausole anti-diluizione collegate a RSU precedentemente assegnate, per riflettere il pagamento di un dividendo in contanti da parte di Accenture. Il prezzo dichiarato per azione è $247,57 e la quantità posseduta a fini benefici dopo la transazione risulta essere 8.473 azioni. Il Modulo 4 è stato firmato per conto del Sig. Sarin da un procuratore il 08/18/2025.

Arun Sarin, director de Accenture plc (símbolo ACN), informó el 15/08/2025 la adquisición de 8.473 acciones ordinarias Clase A mediante una concesión (Código de transacción A) de unidades de acciones restringidas. La concesión se realizó conforme a disposiciones anti-dilución vinculadas a RSU concedidas anteriormente, para reflejar el pago de un dividendo en efectivo por parte de Accenture. El precio informado por acción es $247,57 y la cantidad de acciones de las que es beneficiario tras la operación se indica como 8.473 acciones. El Formulario 4 fue firmado en nombre del Sr. Sarin por un apoderado el 18/08/2025.

Arun Sarin은(는) Accenture plc(티커 ACN)의 이사로서 2025-08-15에 제한부 주식 단위(RSU)의 지급(거래 코드 A)을 통해 8,473 보통주(클래스 A)를 취득했다고 신고했습니다. 이번 지급은 이전에 부여된 RSU와 연계된 희석 방지 조항에 따라 Accenture의 현금 배당 지급을 반영하기 위해 이루어졌습니다. 신고된 주당 가액은 $247.57이며, 거래 후 실질적 소유 주식 수는 8,473주로 기재되어 있습니다. 서식 4는 2025-08-18에 Sarin 씨를 대리한 법정대리인이 서명했습니다.

Arun Sarin, administrateur d'Accenture plc (symbole ACN), a déclaré le 15/08/2025 l'acquisition de 8 473 actions ordinaires de classe A par attribution (code de transaction A) d'unités d'actions restreintes. L'attribution a été effectuée en vertu de dispositions anti-dilution liées à des RSU attribuées antérieurement, afin de refléter le paiement d'un dividende en numéraire par Accenture. Le prix déclaré par action est de 247,57 $ et la quantité détenue bénéficiant d'un droit après la transaction est indiquée comme 8 473 actions. Le Formulaire 4 a été signé le 18/08/2025 pour le compte de M. Sarin par un mandataire.

Arun Sarin, Direktor von Accenture plc (Ticker ACN), meldete am 15.08.2025 den Erwerb von 8.473 Class-A-Stammaktien durch eine Zuteilung (Transaktionskode A) von Restricted Share Units. Die Zuteilung erfolgte aufgrund von Anti-Dilution-Bestimmungen in Verbindung mit zuvor gewährten RSUs, um Accentures Auszahlung einer Bardividende zu berücksichtigen. Der angegebene Preis pro Aktie beträgt $247,57, und der nach der Transaktion wirtschaftlich gehaltene Bestand wird mit 8.473 Aktien angegeben. Das Formular 4 wurde am 18.08.2025 im Namen von Herrn Sarin von einem Bevollmächtigten unterschrieben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Director received RSUs adjusted for a cash dividend, a routine anti-dilution mechanic that preserves economic value of prior awards.

The filing documents a nonsale acquisition of 8,473 Class A ordinary shares by a sitting director through adjustment of previously granted restricted share units. This is described as an anti-dilution grant tied to a dividend payment, which is a common administrative action to preserve the economic interest of equity awards when dividends are paid in cash. There is no disclosure of option exercises, cash outlay by the director, or changes to director status. For governance review, this is procedural and does not signal a change in control, compensation policy, or director independence.

TL;DR: Form 4 shows a standard acquisition of shares via RSU adjustment; transaction code and amounts are clearly reported.

The Form 4 reports Transaction Code A for an acquisition of 8,473 shares at a reported price of $247.57, with the filename indicating these are non-derivative securities converted from RSUs under anti-dilution provisions. This is a regulatory disclosure of insider holdings and meets Section 16 reporting requirements. No dispositions, derivative positions, or additional compensatory arrangements beyond the anti-dilution note are disclosed. Impact on float or ownership percentage is not provided in the filing.

Arun Sarin, direttore di Accenture plc (ticker ACN), ha comunicato in data 08/15/2025 l'acquisizione di 8.473 azioni ordinarie di classe A tramite attribuzione (Codice transazione A) di unità azionarie soggette a restrizioni. L'attribuzione è stata effettuata in applicazione di clausole anti-diluizione collegate a RSU precedentemente assegnate, per riflettere il pagamento di un dividendo in contanti da parte di Accenture. Il prezzo dichiarato per azione è $247,57 e la quantità posseduta a fini benefici dopo la transazione risulta essere 8.473 azioni. Il Modulo 4 è stato firmato per conto del Sig. Sarin da un procuratore il 08/18/2025.

Arun Sarin, director de Accenture plc (símbolo ACN), informó el 15/08/2025 la adquisición de 8.473 acciones ordinarias Clase A mediante una concesión (Código de transacción A) de unidades de acciones restringidas. La concesión se realizó conforme a disposiciones anti-dilución vinculadas a RSU concedidas anteriormente, para reflejar el pago de un dividendo en efectivo por parte de Accenture. El precio informado por acción es $247,57 y la cantidad de acciones de las que es beneficiario tras la operación se indica como 8.473 acciones. El Formulario 4 fue firmado en nombre del Sr. Sarin por un apoderado el 18/08/2025.

Arun Sarin은(는) Accenture plc(티커 ACN)의 이사로서 2025-08-15에 제한부 주식 단위(RSU)의 지급(거래 코드 A)을 통해 8,473 보통주(클래스 A)를 취득했다고 신고했습니다. 이번 지급은 이전에 부여된 RSU와 연계된 희석 방지 조항에 따라 Accenture의 현금 배당 지급을 반영하기 위해 이루어졌습니다. 신고된 주당 가액은 $247.57이며, 거래 후 실질적 소유 주식 수는 8,473주로 기재되어 있습니다. 서식 4는 2025-08-18에 Sarin 씨를 대리한 법정대리인이 서명했습니다.

Arun Sarin, administrateur d'Accenture plc (symbole ACN), a déclaré le 15/08/2025 l'acquisition de 8 473 actions ordinaires de classe A par attribution (code de transaction A) d'unités d'actions restreintes. L'attribution a été effectuée en vertu de dispositions anti-dilution liées à des RSU attribuées antérieurement, afin de refléter le paiement d'un dividende en numéraire par Accenture. Le prix déclaré par action est de 247,57 $ et la quantité détenue bénéficiant d'un droit après la transaction est indiquée comme 8 473 actions. Le Formulaire 4 a été signé le 18/08/2025 pour le compte de M. Sarin par un mandataire.

Arun Sarin, Direktor von Accenture plc (Ticker ACN), meldete am 15.08.2025 den Erwerb von 8.473 Class-A-Stammaktien durch eine Zuteilung (Transaktionskode A) von Restricted Share Units. Die Zuteilung erfolgte aufgrund von Anti-Dilution-Bestimmungen in Verbindung mit zuvor gewährten RSUs, um Accentures Auszahlung einer Bardividende zu berücksichtigen. Der angegebene Preis pro Aktie beträgt $247,57, und der nach der Transaktion wirtschaftlich gehaltene Bestand wird mit 8.473 Aktien angegeben. Das Formular 4 wurde am 18.08.2025 im Namen von Herrn Sarin von einem Bevollmächtigten unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sarin Arun

(Last) (First) (Middle)
C/O ACCENTURE
500 W. MADISON STREET

(Street)
CHICAGO IL 60661

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A ordinary shares 08/15/2025 A 4(1) A $247.57 8,473 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.
Remarks:
/s/ Danika Haueisen, Attorney-In-Fact for Arun Sarin 08/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Arun Sarin report on Form 4 for ACN?

He reported an acquisition of 8,473 Class A ordinary shares via an RSU grant adjusted for a cash dividend on 08/15/2025.

What does Transaction Code A mean on this Form 4?

Transaction Code A indicates an acquisition of securities, here reflecting the grant/adjustment of restricted share units.

Was cash paid by the reporting person for these shares?

The filing describes an anti-dilution RSU grant to reflect a cash dividend; it does not disclose any cash paid by the reporting person.

How many shares did Arun Sarin own after the transaction?

The Form 4 states the amount beneficially owned following the reported transaction as 8,473 shares.

When was the Form 4 signed and filed?

The signature on the form is dated 08/18/2025, signed by an attorney-in-fact for Arun Sarin.
Accenture Plc Ireland

NYSE:ACN

ACN Rankings

ACN Latest News

ACN Latest SEC Filings

ACN Stock Data

158.86B
622.33M
0.08%
82%
1.99%
Information Technology Services
Services-business Services, Nec
Link
Ireland
DUBLIN